The current ITCI market cap is 13.61B. The company's latest EPS is USD -1.3175 and P/E is -97.46.
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 61k | 22.81M | 83.8M | 250.31M | 464.37M |
Operating Income | -154.01M | -231.23M | -285.69M | -263.63M | -159.38M |
Net Income | -147.72M | -227.01M | -284.13M | -256.26M | -139.67M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 251.19M | 717.31M | 489.92M | 754.78M | 728.3M |
Total Liabilities | 56.18M | 60.45M | 72.03M | 98.71M | 136.87M |
Total Equity | 195.01M | 656.86M | 417.89M | 656.07M | 591.42M |
Market Cap | 13.61B |
Price to Earnings Ratio | -97.46 |
Price to Sales Ratio | 29.32 |
Price to Cash Ratio | 92.13 |
Price to Book Ratio | 23.02 |
Dividend Yield | - |
Shares Outstanding | 106.02M |
Average Volume (1 week) | 1.7M |
Average Volume (1 Month) | 2.01M |
52 Week Change | 83.67% |
52 Week High | 128.86 |
52 Week Low | 63.30 |
Spread (Intraday) | 0.02 (0.02%) |
Company Name | Intra Cellular Therapies Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.intracellulartherapies.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions